In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cenestin Drug Master File in Korea (Cenestin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cenestin. The MFDS reviews the Cenestin KDMF as part of the drug registration process and uses the information provided in the Cenestin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cenestin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cenestin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cenestin suppliers with KDMF on PharmaCompass.